In the AJVR article, “Glycyrrhizin alleviated cisplatin-induced testicular injury by inhibiting the oxidative, apoptotic, hormonal, and histological alterations” (Am J Vet Res. Published online November 7, 2024. doi:10.2460/ajvr.24.10.0288), the following correction is needed.
The original Figure 1 image was incorrect. The authors would like to correct their article by amending the image to the following:
Effect of cisplatin (CIS) and glycyrrhizin (GLZ) on the body weight; testicular weight; levels of serum testosterone, luteinizing hormone (LH), follicle-stimulating hormone (FSH), and some antioxidant enzymes (catalase [CAT], superoxide dismutase [SOD], and glutathione peroxidase [GPx]); seminiferous tubular diameters; and sperm abnormality percentages for all experimental groups. According to the Duncan multiple test, the different letters (a–d) are significantly different between treatments at the P < .05 level. G1 = Control group (G1). G2 = CIS-treated group. G3 = GLZ-treated group. G4 = GLZ plus CIS.
Citation: American Journal of Veterinary Research 86, 2; 10.2460/ajvr.24.10.0288cx